NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability

The cancer-testis antigen NY-ESO-1 has been used as a target for different immunotherapies like vaccinations and adoptive transfer of antigen-specific cytotoxic T cells, as it is expressed in various tumor types and has limited expression in normal cells. The in vitro generation of T cells with defi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommermeyer, Daniel, Conrad, Heinke, Krönig, Holger, Gelfort, Haike, Bernhard, Helga, Uckert, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2013
Materias:
Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617456/
https://www.ncbi.nlm.nih.gov/pubmed/22907642
http://dx.doi.org/10.1002/ijc.27792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617456/
https://www.ncbi.nlm.nih.gov/pubmed/22907642
http://dx.doi.org/10.1002/ijc.27792

Ejemplares similares